• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

UDP-糖、UDP和Mg对人肝微粒体中尿苷二磷酸葡萄糖醛酸基转移酶活性的影响。

The effects of UDP-sugars, UDP and Mgon uridine diphosphate glucuronosyltransferase activity in human liver microsomes.

作者信息

Walia Gurinder, Smith Alexander D, Riches Zoe, Collier Abby C, Coughtrie Michael W H

机构信息

a Faculty of Pharmaceutical Sciences, The University of British Columbia , Vancouver , Canada.

出版信息

Xenobiotica. 2018 Sep;48(9):882-890. doi: 10.1080/00498254.2017.1376260. Epub 2017 Sep 26.

DOI:10.1080/00498254.2017.1376260
PMID:28868965
Abstract
  1. The UDP-glucuronosyltransferase (UGT) enzymes are important in the metabolism, elimination and detoxification of many xenobiotics and endogenous compounds. As extrapolation of in vitro kinetics of drug metabolizing enzymes to predict in vivo clearance rates becomes more sophisticated, it is important to ensure proper optimization of enzyme assays. The luminal location of the enzyme active site (i.e. latency), and the complexity of UGT kinetics, results in consistent under-prediction of clearance of drugs metabolized by glucuronidation. 2. We examined inhibition of UGT activity in alamethicin-disrupted human liver microsomes (HLM) by uridine diphosphate (UDP), a UGT reaction product, and its reversal by Mg ions. We also determined whether UDP-sugars other than the co-substrate UDP-glucuronic acid (UDP-GlcA) affected glucuronidation. 3. We show that other UDP-sugars do not significantly influence glucuronidation. We also demonstrate that UDP inhibits HLM UGT activity and that this is reversed by including Mg in the assay. The Mg effect can be offset using EDTA, and is dependent on the concentration of UDP-GlcA in the assay. 4. We propose that formation of a Mg-UDP complex prevents UDP from affecting the enzyme. Our results suggest that 5 mM UDP-GlcA and 10 mM Mg be used for UGT assays in fully disrupted HLM.
摘要
  1. 尿苷二磷酸葡萄糖醛酸基转移酶(UGT)在许多外源性物质和内源性化合物的代谢、消除及解毒过程中发挥着重要作用。随着将药物代谢酶的体外动力学外推以预测体内清除率的方法变得越来越复杂,确保酶分析的适当优化至关重要。酶活性位点的腔定位(即潜伏性)以及UGT动力学的复杂性,导致对经葡萄糖醛酸化代谢的药物清除率的预测始终偏低。2. 我们研究了尿苷二磷酸(UDP),一种UGT反应产物,对阿拉霉素破坏的人肝微粒体(HLM)中UGT活性的抑制作用,以及镁离子对其抑制作用的逆转。我们还确定了除共底物尿苷二磷酸葡萄糖醛酸(UDP-GlcA)之外的其他UDP-糖是否会影响葡萄糖醛酸化。3. 我们发现其他UDP-糖对葡萄糖醛酸化没有显著影响。我们还证明UDP会抑制HLM的UGT活性,并且在分析中加入镁可以逆转这种抑制作用。镁的作用可以用乙二胺四乙酸(EDTA)抵消,并且取决于分析中UDP-GlcA的浓度。4. 我们提出镁-UDP复合物的形成可防止UDP影响酶。我们的结果表明,在完全破坏的HLM中进行UGT分析时应使用5 mM UDP-GlcA和10 mM镁。

相似文献

1
The effects of UDP-sugars, UDP and Mgon uridine diphosphate glucuronosyltransferase activity in human liver microsomes.UDP-糖、UDP和Mg对人肝微粒体中尿苷二磷酸葡萄糖醛酸基转移酶活性的影响。
Xenobiotica. 2018 Sep;48(9):882-890. doi: 10.1080/00498254.2017.1376260. Epub 2017 Sep 26.
2
Characterisation of UDP-glucuronosyltransferase activity in sea turtle .海龟中尿苷二磷酸葡萄糖醛酸基转移酶活性的表征
Xenobiotica. 2022 Dec;52(12):1011-1019. doi: 10.1080/00498254.2022.2164750. Epub 2023 Jan 16.
3
Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.UDP对UDP-葡萄糖醛酸基转移酶(UGT)的产物抑制作用掩盖了UGT底物的抑制效果。
Drug Metab Dispos. 2008 Feb;36(2):361-7. doi: 10.1124/dmd.107.018705. Epub 2007 Nov 12.
4
Carrier-mediated transport of uridine diphosphoglucuronic acid across the endoplasmic reticulum membrane is a prerequisite for UDP-glucuronosyltransferase activity in rat liver.尿苷二磷酸葡糖醛酸经载体介导的内质网膜转运是大鼠肝脏中尿苷二磷酸葡糖醛酸基转移酶活性的前提条件。
Biochem J. 1997 May 1;323 ( Pt 3)(Pt 3):645-8. doi: 10.1042/bj3230645.
5
Highly selective N-glucuronidation of four piperazine-containing drugs by UDP-glucuronosyltransferase 2B10.四氢唑啉、赛洛唑啉、右美沙芬和安非拉酮的 UDP-葡糖醛酸基转移酶 2B10 高选择性 N-葡糖醛酸化。
Expert Opin Drug Metab Toxicol. 2018 Sep;14(9):989-998. doi: 10.1080/17425255.2018.1505862. Epub 2018 Aug 2.
6
Inhibitory effects of uridine diphosphate on UDP-glucuronosyltransferase.尿苷二磷酸对尿苷二磷酸葡萄糖醛酸基转移酶的抑制作用。
Life Sci. 1998;63(19):1693-9. doi: 10.1016/s0024-3205(98)00441-x.
7
ATP serves as an endogenous inhibitor of UDP-glucuronosyltransferase (UGT): a new insight into the latency of UGT.三磷酸腺苷(ATP)作为尿苷二磷酸葡萄糖醛酸转移酶(UGT)的内源性抑制剂:对 UGT 潜伏性的新认识。
Drug Metab Dispos. 2012 Nov;40(11):2081-9. doi: 10.1124/dmd.112.046862. Epub 2012 Jul 30.
8
Prediction of drug clearance by glucuronidation from in vitro data: use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes.从体外数据预测葡萄糖醛酸化介导的药物清除率:在阿拉米辛激活的人肝微粒体中联合使用细胞色素P450和尿苷二磷酸葡萄糖醛酸转移酶辅助因子
Drug Metab Dispos. 2009 Jan;37(1):82-9. doi: 10.1124/dmd.108.023853. Epub 2008 Oct 2.
9
Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation.克隆表达的人胆红素UDP-葡萄糖醛酸基转移酶的底物特异性研究:UDP-糖特异性及其在类固醇和外源性物质葡萄糖醛酸化中的作用。
Biochem J. 1994 Oct 1;303 ( Pt 1)(Pt 1):233-40. doi: 10.1042/bj3030233.
10
The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential.预测人体药物葡萄糖醛酸化参数:用于反应表型分析的 UDP-葡萄糖醛酸基转移酶酶选择性底物和抑制剂探针,以及用于预测药物清除率和药物相互作用潜力的体外-体内外推。
Drug Metab Rev. 2010 Feb;42(1):196-208. doi: 10.3109/03602530903210716.

引用本文的文献

1
The broad range di- and tri-nucleotide exchanger SLC35B1 displays asymmetrical affinities for ATP transport across the ER membrane.广泛存在的二核苷酸和三核苷酸交换器 SLC35B1 对 ER 膜上 ATP 转运表现出不对称的亲和力。
J Biol Chem. 2022 Apr;298(4):101537. doi: 10.1016/j.jbc.2021.101537. Epub 2022 Jan 15.
2
Enzyme Kinetics of Uridine Diphosphate Glucuronosyltransferases (UGTs).尿苷二磷酸葡萄糖醛酸基转移酶(UGTs)的酶动力学。
Methods Mol Biol. 2021;2342:301-338. doi: 10.1007/978-1-0716-1554-6_12.